Infliximab Monoclonal Antibody from Germany
Infliximab is a chimeric monoclonal antibody that neutralizes TNF-alpha and is used to treat Crohn's disease, psoriasis, and other autoimmune conditions. Imported as an unmixed bulk product without retail packaging, it is classified under tariff item 3002.13.00.
Duty Rate — Germany → Canada
0%
Import Tips
• Confirm the product is not mixed with any stabilizers or preservatives to maintain the unmixed classification
• Provide a detailed product description to CBSA, including the biotechnological production method
• Check if the import requires a Health Canada authorization for the intended therapeutic use